Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma
- 1 June 1999
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 140 (1-2) , 81-91
- https://doi.org/10.1016/s0304-3835(99)00055-5
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 24 references indexed in Scilit:
- Bax suppresses tumorigenesis and stimulates apoptosis in vivoNature, 1997
- Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.Journal of Clinical Investigation, 1996
- Tumor suppressor p53 is a direct transcriptional activator of the human bax geneCell, 1995
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 allelesCell, 1992
- Social controls on cell survival and cell deathNature, 1992
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991